LifeStance Health Group, Inc. (LFST) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $14.50M; Long-term Debt, Excluding Current MaturitiesUSD $258.99M; Long-term DebtUSD $275.50M; Long-Term Debt, Maturity, Remainder of Fiscal YearUSD $7.25M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $18.12M; Long-term Debt, Excluding Current MaturitiesUSD $262.46M; Long-term DebtUSD $282.75M; Long-Term Debt, Maturity, Remainder of Fiscal YearUSD $14.50M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $14.50M; Long-term Debt, Excluding Current MaturitiesUSD $265.93M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Remainder of Fiscal YearUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $282.75M; Long-Term Debt, Maturity, Remainder of Fiscal YearUSD (m).
LifeStance Health Group, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Long-term Debt, Fair Value USD | Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Five USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.50M | $258.99M | $275.50M | $7.25M | (m) | $272.67M | $14.50M | $21.75M | $232.00M | (m) | (m) | $-2.01M | (m) |
| 2026-03-31 | $18.12M | $262.46M | $282.75M | $14.50M | (m) | $274.60M | $14.50M | $21.75M | $232.00M | (m) | (m) | $-2.17M | (m) |
| 2025-12-31 | $14.50M | $265.93M | (m) | (m) | (m) | $277.15M | (m) | (m) | (m) | (m) | (m) | $-2.32M | (m) |
| 2025-12-31 | (m) | (m) | $282.75M | (m) | (m) | (m) | $14.50M | $14.50M | $21.75M | $232.00M | (m) | (m) | (m) |
| 2025-09-30 | $12.69M | $269.39M | $284.56M | $1.81M | $269.39M | $281.48M | $14.50M | $14.50M | $21.75M | $232.00M | (m) | (m) | (m) |
| 2025-06-30 | $10.88M | $272.86M | $286.38M | $3.62M | $272.86M | $284.48M | $14.50M | $14.50M | $21.75M | $232.00M | (m) | (m) | (m) |
| 2025-03-31 | $9.06M | $276.32M | $288.19M | $5.44M | $276.32M | $279.39M | $14.50M | $14.50M | $21.75M | $232.00M | (m) | (m) | (m) |
| 2024-12-31 | $7.25M | $279.79M | (m) | (m) | (m) | $287.11M | (m) | (m) | (m) | (m) | (m) | $2.96M | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | $279.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $290.00M | (m) | (m) | (m) | $7.25M | $14.50M | $14.50M | $21.75M | $232.00M | (m) | (m) |
| 2024-09-30 | $2.92M | $279.06M | $287.30M | (m) | $279.06M | $306.10M | $731.00K | $2.92M | $2.92M | $2.92M | $277.79M | (m) | (m) |
| 2024-06-30 | $2.92M | $279.46M | $288.03M | (m) | $279.46M | $305.97M | $1.46M | $2.92M | $2.92M | $2.92M | $277.79M | (m) | (m) |
| 2024-03-31 | $2.92M | $279.87M | $288.76M | (m) | $279.87M | $306.81M | $2.19M | $2.92M | $2.92M | $2.92M | $277.79M | (m) | (m) |
| 2023-12-31 | $2.92M | $280.29M | $289.49M | (m) | $280.29M | $304.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $2.92M | $2.92M | $2.92M | $2.92M | $277.79M | (m) | (m) |
| 2023-09-30 | $2.60M | $248.37M | $257.14M | (m) | $248.37M | $263.47M | $649.00K | $2.60M | $2.60M | $2.60M | $2.60M | (m) | $246.11M |
| 2023-06-30 | $2.60M | $248.72M | $257.79M | (m) | $248.72M | $262.68M | $1.30M | $2.60M | $2.60M | $2.60M | $2.60M | (m) | $246.11M |
| 2023-03-31 | $2.35M | $224.76M | $233.38M | (m) | $224.76M | $237.45M | $1.76M | $2.35M | $2.35M | $2.35M | $2.35M | (m) | $222.24M |
| 2022-12-31 | $2.35M | $225.08M | $233.96M | (m) | $225.08M | $235.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.35M | $2.35M | $2.35M | $2.35M | (m) | (m) |
| 2022-09-30 | $2.15M | $212.04M | $220.50M | (m) | $212.04M | $210.43M | $536.00K | $2.15M | $2.15M | $2.15M | $2.15M | (m) | $211.38M |
| 2022-06-30 | $1.50M | $203.36M | $211.00M | (m) | $203.36M | $192.30M | $500.00K | $2.00M | $2.00M | $2.00M | $2.00M | (m) | $202.50M |
| 2022-03-31 | $1.32M | $177.38M | $180.90M | (m) | $177.38M | $196.95M | (m) | $992.00K | $1.32M | $1.32M | $21.32M | (m) | (m) |
| 2021-12-31 | $1.32M | $157.42M | $161.23M | (m) | $157.42M | $186.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.32M | $1.32M | $1.32M | $1.32M | (m) | (m) |
| 2021-09-30 | $1.32M | $157.45M | $161.56M | (m) | $157.45M | $187.78M | $331.00K | $1.32M | $1.32M | $1.32M | $1.32M | (m) | $155.94M |
| 2021-06-30 | $1.62M | $157.07M | $161.89M | (m) | $157.07M | $190.17M | $809.00K | $1.62M | $1.62M | $1.62M | $1.62M | (m) | $154.61M |
| 2020-12-31 | $3.74M | $362.53M | $373.82M | (m) | $362.53M | $458.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |